Skip to main content
NGNE logo

NGNE · Neurogene Inc.

Track NGNE — free
$38.07 +0.08 (+0.21%)
Market Cap
$789.05M
Shares
20.01M

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Equity Offering (ATM) Programs

Program Established Capacity Remaining Runs Through
2025-08-11 $150,000,000 $112,900,000 as of 2026-06-30
Key facts CIK 1404644 CUSIP 64135M105 13F (30d) 110 filings 107 filers Visit website